Can vaginal splinting cause a urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Vaginal Splinting Cause a UTI?

Yes, vaginal splinting (vaginal digitation) is significantly associated with recurrent urinary tract infections in women and should be considered a contributory risk factor.

The Evidence

The most recent and highest quality evidence directly addressing this question comes from a 2025 multicentre case-control study analyzing 7,990 women using validated patient-reported outcome measures 1. This study demonstrated that perineal splinting/vaginal digitation was significantly associated with recurrent UTI (p < 0.0001, OR 1.19), along with other bowel dysfunction symptoms including anal incontinence.

Understanding the Mechanism

The pathogenesis follows a logical anatomical pathway:

  • UTIs in women occur via ascending infection when bowel flora from the anus colonize the periurethral area and ascend to cause bacterial cystitis 2
  • Vaginal splinting compensates for pelvic floor defects, particularly rectoceles (present in 86.2% of women who splint) and cystoceles (75.9%) 3
  • The proximity between anus and vagina allows uropathogens from intestinal microbiota to colonize the vaginal introitus during manual manipulation 4
  • Vaginal microbiota disruption from repeated digital manipulation may replace protective lactobacilli with gram-negative bacteria like E. coli, which causes approximately 75% of recurrent UTIs 2

Clinical Implications

Risk Stratification

Women who report needing vaginal splinting for defecation should be:

  • Evaluated for underlying pelvic floor defects (rectocele, cystocele, enterocele) that necessitate the splinting behavior 3
  • Counseled about UTI risk as part of their pelvic floor dysfunction management
  • Assessed for other anatomical abnormalities that constitute complicated UTI risk factors, including cystoceles and high postvoid residuals 2

Management Approach

According to current guidelines 2, 5:

  1. Address the underlying pelvic floor defect - MRI with splinting protocol can identify correctable anatomical defects in 96.6% of cases 3

  2. Implement behavioral modifications first before antibiotic prophylaxis:

    • Adequate hydration to promote frequent urination
    • Urge-initiated voiding
    • Post-coital voiding if sexually active
    • For postmenopausal women: vaginal estrogen therapy 5
  3. Consider non-antibiotic prophylaxis:

    • Vaginal probiotics containing Lactobacillus (to restore protective vaginal flora disrupted by splinting) 6
    • Cranberry products (minimum 36 mg/day proanthocyanidin A) 6, 5
  4. Reserve antibiotic prophylaxis for women with ≥3 UTIs in 12 months who have failed conservative measures 2, 6

Important Caveats

  • Correlation does not equal causation alone - the association is significant but the relationship is multifactorial
  • Splinting indicates underlying pathology - the pelvic floor defect itself (particularly cystocele with incomplete bladder emptying) may be the primary UTI risk factor, with splinting serving as a marker 2
  • The weak correlation coefficient (r = 0.069-0.151) suggests splinting is one of multiple contributing factors rather than the sole cause 1

Bottom Line

Vaginal splinting should be recognized as a clinical marker for both pelvic floor dysfunction and increased UTI risk. Women reporting this behavior warrant comprehensive pelvic floor evaluation and targeted interventions addressing both the anatomical defects necessitating splinting and UTI prevention strategies, prioritizing non-antibiotic approaches when possible 2, 5, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.